Literature DB >> 1689900

Effect of hepatic dysfunction and T tube clamping on FK 506 pharmacokinetics and trough concentrations.

A B Jain1, R Venkataramanan, E Cadoff, J J Fung, S Todo, A Krajack, T E Starzl.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1990        PMID： 1689900      PMCID： PMC2943675     

Source DB:  PubMed          Journal:  Transplant Proc        ISSN： 0041-1345            Impact factor:   1.066


× No keyword cloud information.
  3 in total

1.  A highly sensitive method to assay FK-506 levels in plasma.

Authors:  K Tamura; M Kobayashi; K Hashimoto; K Kojima; K Nagase; K Iwasaki; T Kaizu; H Tanaka; M Niwa
Journal:  Transplant Proc       Date:  1987-10       Impact factor: 1.066

2.  FK 506 for liver, kidney, and pancreas transplantation.

Authors:  T E Starzl; S Todo; J Fung; A J Demetris; R Venkataramman; A Jain
Journal:  Lancet       Date:  1989-10-28       Impact factor: 79.321

3.  Effect of bile on cyclosporin absorption in liver transplant patients.

Authors:  M U Mehta; R Venkataramanan; G J Burckart; R J Ptachcinski; B Delamos; S Stachak; D H Van Thiel; S Iwatsuki; T E Starzl
Journal:  Br J Clin Pharmacol       Date:  1988-05       Impact factor: 4.335
  3 in total
  34 in total

1.  Intravenous, oral pharmacokinetics, and oral dosing of FK 506 in small bowel transplant patients.

Authors:  A Jain; R Venkataramanan; S Todo; K Abu-Elmagd; J Fung; V Warty; A Tzakis; J Reyes; M Alessiani; T E Starzl
Journal:  Transplant Proc       Date:  1992-06       Impact factor: 1.066

2.  Evaluation of limited sampling methods for estimation of tacrolimus exposure in adult kidney transplant recipients.

Authors:  Katherine A Barraclough; Nicole M Isbel; Carl M Kirkpatrick; Katie J Lee; Paul J Taylor; David W Johnson; Scott B Campbell; Diana R Leary; Christine E Staatz
Journal:  Br J Clin Pharmacol       Date:  2011-02       Impact factor: 4.335

3.  Strategy of FK 506 therapy in liver transplant patients: effect of graft function.

Authors:  K M Abu-Elmagd; J J Fung; M Alessiani; A Jain; S Takaya; R Venkataramanan; V S Warty; W Shannon; S Todo; A Tzakis
Journal:  Transplant Proc       Date:  1991-12       Impact factor: 1.066

4.  Evaluation of a novel "intelligent" dosing system for optimizing FK 506 therapy.

Authors:  J McMichael; W Irish; J McCauley; R Shapiro; R Gordon; D H Van Thiel; R Lieberman; V S Warty; J Fung; T E Starzl
Journal:  Transplant Proc       Date:  1991-12       Impact factor: 1.066

5.  Comparative study of cyclosporine and FK 506 dosage requirements in adult and pediatric orthotopic liver transplant patients.

Authors:  A B Jain; J J Fung; A G Tzakis; R Venkataramanan; K Abu-Elmagd; M Alessiani; J Reyes; W Irish; V Warty; S Mehta
Journal:  Transplant Proc       Date:  1991-12       Impact factor: 1.066

6.  Four-hour versus 24-hour intravenous infusion of FK 506 in liver transplantation.

Authors:  K M Abu-Elmagd; J Fung; R Draviam; W Shannon; A Jain; M Alessiani; S Takaya; R Venkataramanan; V S Warty; A Tzakis
Journal:  Transplant Proc       Date:  1991-12       Impact factor: 1.066

7.  The effect of FK 506 on peripheral blood T-lymphocyte subsets in orthotopic liver transplant patients.

Authors:  A Yagihashi; Y Yoshida; K Terasawa; Y Ujike; A Konno; K Ogura; M Kobayashi; T Takenaka; S Hayashi; R Selby
Journal:  Transplant Proc       Date:  1991-12       Impact factor: 1.066

8.  Correlation between bioassayed plasma levels of FK 506 and lymphocyte growth from liver transplant biopsies with histological evidence of rejection.

Authors:  A Zeevi; G Eiras; C Kaufman; M Alessiani; A J Demetris; K Abu-Elmagd; A Jain; V Warty; R Venkataramanan; G Burckart
Journal:  Transplant Proc       Date:  1991-02       Impact factor: 1.066

9.  Kidney transplantation under FK 506 immunosuppression.

Authors:  R Shapiro; M Jordan; J Fung; J McCauley; J Johnston; Y Iwaki; A Tzakis; T Hakala; S Todo; T E Starzl
Journal:  Transplant Proc       Date:  1991-02       Impact factor: 1.066

Review 10.  A risk-benefit assessment of tacrolimus in transplantation.

Authors:  M Winkler; U Christians
Journal:  Drug Saf       Date:  1995-05       Impact factor: 5.606
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.